MICROBIOL SPECTR 润色咨询

Microbiology Spectrum

出版年份：暂无数据 年文章数：2675 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2256065, encodeId=76412256065d7, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：一个月了在under peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8739375117, createdName=ms8000000006160534, createdTime=Fri Mar 14 14:54:20 CST 2025, time=2025-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30<br>Under Peer Review 2024-06-26 12:34:29<br>Under Evaluation 2024-06-14 00:54:57<br>Under Peer Review 2024-06-13 03:34:59<br>Under Evaluation 2024-06-13 03:34:59<br>这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：微生物学<br>经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀 还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：感染<br>经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物<br>经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=)]
    2025-03-14 ms8000000006160534 来自上海

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：一个月了在under peer review

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2256065, encodeId=76412256065d7, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：一个月了在under peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8739375117, createdName=ms8000000006160534, createdTime=Fri Mar 14 14:54:20 CST 2025, time=2025-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30<br>Under Peer Review 2024-06-26 12:34:29<br>Under Evaluation 2024-06-14 00:54:57<br>Under Peer Review 2024-06-13 03:34:59<br>Under Evaluation 2024-06-13 03:34:59<br>这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：微生物学<br>经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀 还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：感染<br>经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物<br>经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=)]
    2024-06-27 学医的啊金 来自江苏省

    Under Evaluation 2024-06-26 12:34:30
    Under Peer Review 2024-06-26 12:34:29
    Under Evaluation 2024-06-14 00:54:57
    Under Peer Review 2024-06-13 03:34:59
    Under Evaluation 2024-06-13 03:34:59
    这两个状态一直反复是什么意思啊？

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2256065, encodeId=76412256065d7, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：一个月了在under peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8739375117, createdName=ms8000000006160534, createdTime=Fri Mar 14 14:54:20 CST 2025, time=2025-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30<br>Under Peer Review 2024-06-26 12:34:29<br>Under Evaluation 2024-06-14 00:54:57<br>Under Peer Review 2024-06-13 03:34:59<br>Under Evaluation 2024-06-13 03:34:59<br>这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：微生物学<br>经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀 还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：感染<br>经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物<br>经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=)]
    2024-08-09 ms3000001823604137 来自江苏省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：微生物
    经验分享：小修之后编辑给拒了

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2256065, encodeId=76412256065d7, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：一个月了在under peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8739375117, createdName=ms8000000006160534, createdTime=Fri Mar 14 14:54:20 CST 2025, time=2025-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30<br>Under Peer Review 2024-06-26 12:34:29<br>Under Evaluation 2024-06-14 00:54:57<br>Under Peer Review 2024-06-13 03:34:59<br>Under Evaluation 2024-06-13 03:34:59<br>这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：微生物学<br>经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀 还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：感染<br>经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物<br>经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=)]
    2024-09-10 ms5000000014275476 来自山东省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：微生物学
    经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2256065, encodeId=76412256065d7, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：一个月了在under peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8739375117, createdName=ms8000000006160534, createdTime=Fri Mar 14 14:54:20 CST 2025, time=2025-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30<br>Under Peer Review 2024-06-26 12:34:29<br>Under Evaluation 2024-06-14 00:54:57<br>Under Peer Review 2024-06-13 03:34:59<br>Under Evaluation 2024-06-13 03:34:59<br>这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：微生物学<br>经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀 还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：感染<br>经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物<br>经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=)]
    2024-07-10 ms5000001800800166 来自重庆

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：微生物
    经验分享：审稿人意见很中肯

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2256065, encodeId=76412256065d7, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：一个月了在under peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8739375117, createdName=ms8000000006160534, createdTime=Fri Mar 14 14:54:20 CST 2025, time=2025-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30<br>Under Peer Review 2024-06-26 12:34:29<br>Under Evaluation 2024-06-14 00:54:57<br>Under Peer Review 2024-06-13 03:34:59<br>Under Evaluation 2024-06-13 03:34:59<br>这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：微生物学<br>经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀 还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：感染<br>经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物<br>经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=)]
    2023-09-21 浩浩Peter 来自内蒙古

    缴费以后多久收到proof呀 还有proof之后多久online

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2256065, encodeId=76412256065d7, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：一个月了在under peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8739375117, createdName=ms8000000006160534, createdTime=Fri Mar 14 14:54:20 CST 2025, time=2025-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30<br>Under Peer Review 2024-06-26 12:34:29<br>Under Evaluation 2024-06-14 00:54:57<br>Under Peer Review 2024-06-13 03:34:59<br>Under Evaluation 2024-06-13 03:34:59<br>这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：微生物学<br>经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀 还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：感染<br>经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物<br>经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=)]
    2024-06-27 ms5000000350008474 来自广东省

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：完

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2256065, encodeId=76412256065d7, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：一个月了在under peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8739375117, createdName=ms8000000006160534, createdTime=Fri Mar 14 14:54:20 CST 2025, time=2025-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30<br>Under Peer Review 2024-06-26 12:34:29<br>Under Evaluation 2024-06-14 00:54:57<br>Under Peer Review 2024-06-13 03:34:59<br>Under Evaluation 2024-06-13 03:34:59<br>这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：微生物学<br>经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀 还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：感染<br>经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物<br>经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=)]
    2022-05-21 可乐与红茶

    请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2256065, encodeId=76412256065d7, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：一个月了在under peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8739375117, createdName=ms8000000006160534, createdTime=Fri Mar 14 14:54:20 CST 2025, time=2025-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30<br>Under Peer Review 2024-06-26 12:34:29<br>Under Evaluation 2024-06-14 00:54:57<br>Under Peer Review 2024-06-13 03:34:59<br>Under Evaluation 2024-06-13 03:34:59<br>这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：微生物学<br>经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀 还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：感染<br>经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物<br>经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=)]
    2023-09-22 146ee135m37暂无昵称 来自广东省

    审稿速度:24.0 | 投稿命中率:5.0
    偏重的研究方向：感染
    经验分享：在evaluation和peer review之间反复变换怎么回事？求解答

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2256065, encodeId=76412256065d7, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：一个月了在under peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8739375117, createdName=ms8000000006160534, createdTime=Fri Mar 14 14:54:20 CST 2025, time=2025-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30<br>Under Peer Review 2024-06-26 12:34:29<br>Under Evaluation 2024-06-14 00:54:57<br>Under Peer Review 2024-06-13 03:34:59<br>Under Evaluation 2024-06-13 03:34:59<br>这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：微生物学<br>经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：微生物<br>经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀 还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：感染<br>经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物<br>经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=)]
    2022-10-11 121e5ed5m66(暂无昵称)

    偏重的研究方向：微生物
    经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息

    9

    展开9条回复
共128条页码: 1/13页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分